Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026
Referred to the House Committee on Energy and Commerce.
Email me when HR 10094 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track HR 10094. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
HR 10094, the Affordable Pricing for Taxpayer-Funded Prescription Drugs Act of 2026, would address the pricing of prescription medications that are financed by federal programs. It targets patients who receive drugs through taxpayer‑funded programs and the taxpayers themselves, seeking to make those drugs more affordable. The measure is currently referred to the House Committee on Energy and Commerce.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about HR 10094
3 free questions a day, no accountSponsors
- Rep. Hoyle, Val T. [D-OR-4] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when HR 10094 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track HR 10094 freeOr ask your AI assistant about HR 10094 directly:
Add to Claude, ChatGPT or Cursor